Drug Decriminalization in Portugal:
Lessons for Creating Fair and Successful Drug Policies
by Glenn Greenwald
CATO Institute
Prior to bursting onto the scene as a celebrity columnist due to his leadership on the NSA leaks and the Snowden story, Glenn Greenwald wrote on a variety of important issues.
In this White Paper, writing for the CATO Institute, Greenwald analyzes drug decriminalization in Portugal. In 2001, national policy makers in Portugal decided to move from prohibition to a policy focused on rehabilitation and treatment rather than punishment. Given the every growing concern over punitive drug policies and overcrowding prisons in America, this report gives a glimpse into the future of what US policy makers could be thinking next.
Below is the Executive Summary of the paper but you can view the full report
(here).
Here are a few articles that follow-up on the report written by Greenwald in 2006.
--------------------------------------------------------------------------------------------------------------------------
Executive Summary
On July 1, 2001, a nationwide law in Portugal
took effect that decriminalized all drugs, including
cocaine and heroin. Under the new legal
framework, all drugs were “decriminalized,” not
“legalized.” Thus, drug possession for personal
use and drug usage itself are still legally prohibited,
but violations of those prohibitions are
deemed to be exclusively administrative violations
and are removed completely from the criminal
realm. Drug trafficking continues to be
prosecuted as a criminal offense.
While other states in the European Union
have developed various forms of de facto decriminalization—whereby
substances perceived to be
less serious (such as cannabis) rarely lead to criminal
prosecution—Portugal remains the only EU
member state with a law explicitly declaring
drugs to be “decriminalized.” Because more than
seven years have now elapsed since enactment of
Portugal’s decriminalization system, there are
ample data enabling its effects to be assessed.
Notably, decriminalization has become increasingly
popular in Portugal since 2001. Except for
some far-right politicians, very few domestic political
factions are agitating for a repeal of the 2001 law.
And while there is a widespread perception that
bureaucratic changes need to be made to Portugal’s
decriminalization framework to make it more efficient
and effective, there is no real debate about
whether drugs should once again be criminalized.
More significantly, none of the nightmare scenarios
touted by preenactment decriminalization opponents—from
rampant increases in drug usage
among the young to the transformation of Lisbon
into a haven for “drug tourists”—has occurred.
The political consensus in favor of decriminalization
is unsurprising in light of the relevant
empirical data. Those data indicate that decriminalization
has had no adverse effect on drug usage
rates in Portugal, which, in numerous categories,
are now among the lowest in the EU, particularly
when compared with states with stringent criminalization
regimes. Although postdecriminalization
usage rates have remained roughly the same or
even decreased slightly when compared with other
EU states, drug-related pathologies—such as sexually
transmitted diseases and deaths due to drug
usage—have decreased dramatically. Drug policy
experts attribute those positive trends to the
enhanced ability of the Portuguese government to
offer treatment programs to its citizens—enhancements
made possible, for numerous reasons, by
decriminalization.
This report will begin with an examination of
the Portuguese decriminalization framework as
set forth in law and in terms of how it functions
in practice. Also examined is the political climate
in Portugal both pre- and postdecriminalization
with regard to drug policy, and the impetus that
led that nation to adopt decriminalization.
The report then assesses Portuguese drug policy
in the context of the EU’s approach to drugs.
The varying legal frameworks, as well as the overall
trend toward liberalization, are examined to enable
a meaningful comparative assessment between
Portuguese data and data from other EU states.
The report also sets forth the data concerning
drug-related trends in Portugal both pre- and
postdecriminalization. The effects of decriminalization
in Portugal are examined both in
absolute terms and in comparisons with other
states that continue to criminalize drugs, particularly
within the EU.
The data show that, judged by virtually every
metric, the Portuguese decriminalization framework
has been a resounding success. Within this
success lie self-evident lessons that should guide
drug policy debates around the world.